NCT04716322 Health-Enhancing Adapted Physical Activity Program at "Mon Stade"
| NCT ID | NCT04716322 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mon Stade Sports Medicine Centre |
| Condition | Exercise Therapy |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,024 participants |
| Start Date | 2021-01-28 |
| Primary Completion | 2025-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,024 participants in total. It began in 2021-01-28 with a primary completion date of 2025-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Introduction: Regular practice of exercise or physical activity (PA) is a recognized intervention as a determinant of good health acquisition, maintenance, or recovery for a large number of chronic pathologies. Nevertheless, few studies have evaluated adherence to an initial health-adapted PA (APA) program, and persistence of active behavior over the time in individuals with a chronic disease. The aim of the study is to determine the brakes and levers associated with motivation and long-term compliance. In addition, the investigators aim to evaluate the cost-effectiveness of such program in term of care consumption. Finally, the investigators complete their interest for APA prescription from practitioners agreeing to enroll their patients in the present study. Method: The investigators perform a prospective monocentric cohort, of 2024 patients affected of a chronic disease or long-term illness (LTI), enrolled from 2021 to 2024 (4 years, 506 per year), for a 16-week APA program, and followed 5 years with an annual fitness and habits of life and care consumption evaluation.
Eligibility Criteria
Inclusion Criteria: * Male or female * 18 years of age or older * Speaking and understanding French * Affected by a chronic pathology according to a predefined list (LTI, obesity, HTA, COPD, COVID-19 with persistent symptoms) * Carrier of a writing APA prescription * Able to come to "Mon Stade" twice a week for their APA sessions following the 16-week health-adapted PA program; * Signature of the information and consent form. Exclusion Criteria: \- Women whose pregnancy is known
Contact & Investigator
Philippe Sosner, MD, PhD
STUDY DIRECTOR
Mon Stade Sports Medicine Center, Paris, France
Frequently Asked Questions
Who can join the NCT04716322 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Exercise Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04716322 currently recruiting?
Yes, NCT04716322 is actively recruiting participants. Contact the research team at psosner@monstade.fr for enrollment information.
Where is the NCT04716322 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT04716322 clinical trial?
NCT04716322 is sponsored by Mon Stade Sports Medicine Centre. The principal investigator is Philippe Sosner, MD, PhD at Mon Stade Sports Medicine Center, Paris, France. The trial plans to enroll 2,024 participants.